TrialCNS oncology2023

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.

Garni Barkhoudarian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.